Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and tolerability of this treatment
combination of paclitaxel and trametinib. Additionally, this study aims to to find out what
effects the combination of paclitaxel and trametinib has on the shrinkage and growth of
anaplastic thyroid cancer.